STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells

AD80, a multikinase inhibitor, exhibits antineoplastic effects in acute leukemia cellular models targeting the PI3K/STMN1 axis

(2021) Jorge Antonio Elias Godoy Carlos et al.   INVESTIGATIONAL NEW DRUGS

Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells

(2021) Hugo Passos Vicari et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Integration of genomic and transcriptomic markers improves the prognosis prediction of acute promyelocytic leukemia

(2021) Xiao Jing Lin et al.   CLINICAL CANCER RESEARCH

A Glycolysis-Related Five-Gene Signature Predicts Biochemical Recurrence-Free Survival in Patients With Prostate Adenocarcinoma

(2021) Zijun Xu et al.   Frontiers in Oncology

A glycolysis-related gene expression signature in predicting recurrence of breast cancer

(2020) Jianing Tang et al.   Aging-US

Stathmin 1 deficiency induces erythro-megakaryocytic defects leading to macrocytic anemia and thrombocythemia in Stathmin 1 knock out mice

(2020) Charmaine A. Ramlogan-Steel et al.   BLOOD CELLS MOLECULES AND DISEASES

BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparib

(2015) Isabella Faraoni et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors

(2015) Maria Teresa Esposito et al.   NATURE MEDICINE

Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells

(2015) João Agostinho Machado-Neto et al.   Oncotarget

Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation Therapy

(2015) Anna Barbuti et al.   Cancers

Stathmin 1 in normal and malignant hematopoiesis

(2015) Joao Agostinho Machado-Neto et al.   BMB Reports

Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL

(2013) E. M. Rego et al.   BLOOD

Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells

(2013) João Agostinho Machado-Neto et al.   LEUKEMIA RESEARCH

Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Roles for MYC in the Establishment and Maintenance of Pluripotency

(2013) J. Chappell et al.   Cold Spring Harbor Perspectives in Medicine

Down-regulation of stathmin expression is required for megakaryocyte maturation and platelet production

(2011) C. Iancu-Rubin et al.   BLOOD

Stathmin: a protein with many tasks. New biomarker and potential target in cancer

(2011) Barbara Belletti et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Upregulated Op18/stathmin activity causes chromosomal instability through a mechanism that evades the spindle assembly checkpoint

(2010) Per Holmfeldt et al.   EXPERIMENTAL CELL RESEARCH

Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

(2008) M. A. Sanz et al.   BLOOD

Acute promyelocytic leukemia: from highly fatal to highly curable

(2008) Z.-Y. Wang et al.   BLOOD